Kyntra Bio (MEX:KYNB) Issuance of Debt: MXN0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:KYNB Kyntra Bio Inc MEX:KYNB
48 GF Score
Price MXN119.00
GF Value MXN72.50
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Kyntra Bio Issuance of Debt?

Kyntra Bio MEX:KYNB 48 Issuance of Debt is MXN0.00 Mil as of Jun. 2026. GuruFocus rates MEX:KYNB with a GF Score™ of 48/100 and a GF Value™ of MXN72.50 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Kyntra Bio's Issuance of Debt for the three months ended in Jun. 2026 was MXN0.00 Mil.

Kyntra Bio's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was MXN0.00 Mil.

Kyntra Bio Issuance of Debt Related Terms

Kyntra Bio Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Kyntra Bio's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyntra Bio Issuance of Debt Chart

Kyntra Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 1,257.42 0.00 0.00

Kyntra Bio Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:KYNB
48GF Score
Kyntra Bio Inc MEX:KYNB
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kyntra Bio Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of MXN0.00 Mil mean?
Kyntra Bio (MEX:KYNB) has a Issuance of Debt of MXN0.00 Mil as of Jun. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Kyntra Bio and its competitors.
Is Kyntra Bio's Issuance of Debt too high?
Kyntra Bio's current Issuance of Debt is MXN0.00 Mil. Overall, Kyntra Bio has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kyntra Bio's Issuance of Debt compare to ACTU and PLRZ?
Kyntra Bio's Issuance of Debt of MXN0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Biotechnology company?
A good Issuance of Debt depends on the Biotechnology industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Kyntra Bio and its competitors. Kyntra Bio's current Issuance of Debt is MXN0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyntra Bio stock overvalued right now?
Based on GuruFocus' analysis, Kyntra Bio (MEX:KYNB) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN72.50, compared to a current price of MXN119.00 — trading 64.1% above its estimated fair value. The current Issuance of Debt is MXN0.00 Mil. Kyntra Bio's overall GF Score™ is 48/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Kyntra Bio (MEX:KYNB), the current Issuance of Debt is MXN0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kyntra Bio (MEX:KYNB) Overvalued in 2026?

Based on GuruFocus' analysis, Kyntra Bio stock appears to be overvalued. The current stock price of MXN119.00 is trading 64.1% above its estimated GF Value™ of MXN72.50. GuruFocus considers Kyntra Bio to be Significantly Overvalued.

Key valuation signals for MEX:KYNB:

  • Issuance of Debt: MXN0.00 Mil
  • GF Value™: MXN72.50 vs. price of MXN119.00 (64.1% above fair value)
  • GF Score™: 48/100 with 9 warning signs

No single metric tells the full story. See the MEX:KYNB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kyntra Bio Business Description

Other Exchanges KYNB:USA0IL8:UK1FG0:Germany
Address 350 Bay Street, Suite 100, No. 6009, San Francisco, CA, USA, 94133
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
48GF Score

Get the complete analysis for MEX:KYNB

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN119.00
Price
MXN72.50
GF Value